Stocks · Health care · Pharmaceutical Preparations

Akebia Therapeutics, Inc.

AKBA Clue Score38
United States Fiscal year ends December CIK 0001517022 Results filed 5 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Richard C Malabre
9 Jun 2025
SVP, Chief Accounting Officer
Sold after exercise
15,000
$4.01
$60.15K

What was left out

Form 4 filings counted 247
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 30
Sales straight out of an exercise 1
Sales at will 96
Transactions with no price 0
Shares from compensation/vesting 12,885,944
Sales filed before the plan box existed 83
History held since 26 Mar 2014